Fortrea Holdings Inc. (FTRE) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$15.64
Price Target
$18.83
Target Range
$11.00 — $25.00
Analyst Rating
Hold
Forward P/E23.1x
Trailing P/E-1.4x
Forward PEG—
Implied Growth—
Median Target$20.00
Analyst Spread74.3%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$11
-29.7%
Consensus
$19
+20.4%
Bull Case
$25
+59.8%
FTRE Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Fortrea Holdings Inc. (FTRE) has a Wall Street consensus price target of $18.83, based on estimates from 12 covering analysts. With the stock currently trading at $15.64, this represents a potential upside of +20.4%. The company has a market capitalization of $1.46B.
Analyst price targets range from a low of $11.00 to a high of $25.00, representing a 74% spread in expectations. The median target of $20.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 5 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, FTRE trades at a trailing P/E of -1.4x and forward P/E of 23.1x.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+24.3%
Avg Forward P/E21.4x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 IQVIQVIA Holdings Inc. | $29.9B | $176.47 | $225.63 | +27.9% | Buy | 13.9x | 44 |
 CRLCharles River Laboratories International, Inc. | $9.0B | $181.73 | $205.43 | +13.0% | Buy | 16.4x | 36 |
 MEDPMedpace Holdings, Inc. | $12.2B | $426.79 | $498.86 | +16.9% | Hold | 25.1x | 19 |
 PRAProAssurance Corporation | $1.3B | $24.60 | $18.33 | -25.5% | Hold | 21.8x | 11 |
 ICLRICON Public Limited Company | $9.5B | $124.13 | $149.63 | +20.5% | Buy | 10.5x | 30 |
 LHLabcorp Holdings Inc. | $21.1B | $256.93 | $311.33 | +21.2% | Buy | 14.4x | 35 |
 DGXQuest Diagnostics Incorporated | $20.9B | $189.13 | $220.57 | +16.6% | Hold | 17.6x | 34 |
 NVCRNovoCure Limited | $1.9B | $16.50 | $33.50 | +103.1% | Buy | — | 15 |
 HIMSHims & Hers Health, Inc. | $6.9B | $26.88 | $29.67 | +10.4% | Hold | 53.9x | 19 |
 TMOThermo Fisher Scientific Inc. | $175.8B | $472.95 | $654.67 | +38.4% | Buy | 19.0x | 42 |
Upside Potential Comparison
NVCRTMOIQVLHICLRMEDPDGXCRLSee FTRE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FTRE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FTRE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonFTRE — Frequently Asked Questions
Quick answers to the most common questions about buying FTRE stock.
What is the FTRE stock price target for 2026?
The consensus Wall Street price target for FTRE is $18.83, representing 20.4% upside from the current price of $15.64. With 12 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is FTRE a buy, sell, or hold?
FTRE has a consensus rating of "Hold" based on 12 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $18.83 implies 20.4% upside from current levels.
Is FTRE stock overvalued or undervalued?
FTRE trades at a forward P/E of 23.1019x, representing a moderate valuation. With analysts targeting $18.83 (20.4% implied move), the stock appears reasonably valued with upside.
How high can FTRE stock go?
The most bullish Wall Street analyst has a price target of $25 for FTRE, while the most conservative target is $11. The consensus of $18.83 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover FTRE stock?
FTRE is moderately covered, with 12 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the FTRE stock forecast?
The 12-month FTRE stock forecast based on 12 Wall Street analysts shows a consensus price target of $18.83, with estimates ranging from $11 (bear case) to $25 (bull case). The median consensus rating is "Hold".
What is FTRE's forward P/E ratio?
FTRE trades at a forward P/E ratio of 23.1x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy FTRE stock?
Wall Street analysts are very optimistic on FTRE, with a "Hold" consensus rating and $18.83 price target (20.4% upside). 5 of 12 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do FTRE price targets vary so much?
FTRE analyst price targets range from $11 to $25, a 74% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18.83 consensus represents the middle ground.